COX-2在乳腺癌组织中的超微结构定位及其意义(2)
 |
| 第1页 |
参见附件(1558KB，2页)。
[2]Mc Murray RW, Hardy KJ. COX-2 inhibitors:today and tomorrow [J]. Am J Med Sci,2002,323(4):181-189.
[3]Singh B, Berry JA, Shoher A, et al. COX-2 overexpression increases motility and invasion of breast cancer cells [J]. Int J Oncol,2005,26(5):1393-1399.
[4]Nakopoulou L, Mylona E, Papadaki I, et al. Overexpression of cyclooxygenase-2 is associated with a favorable prognostic phenotype in breast carcinoma [J]. Pathobiology,2005,72(5):241-249.
[5]Mohammad AM, Abdel HA, Abdel W, et al. Expression of cyclooxygenase-2 and 12-lipoxygenase in human breast cancer and their relationship with HER-2/neu and hormonal receptors: impact on prognosis and therapy[J]. Indian J Cancer,2006,43(4):163-168.
[6]Denkert C, Winzer KJ, Muller BM, et al. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma [J]. Cancer,2003,97(12):2978-2987.
[7]Singh B, Berry JA, Shoher A, et al. COX-2 induces IL-11 production in human breast cancer cells [J]. J Surg Res,2006,131(2):267-275.
(收稿日期:2010-01-04)
您现在查看是摘要介绍页，详见PDF附件(1558KB，2页)。